Background/Aims: Mild cognitive impairment (MCI) is a frequent syndrome in the older population, which involves an increased risk to develop Alzheimer's disease (AD). The latter can be modified by the cognitive reserve, which can be operationalized by the length of school education. MCI can be differentiated into four subtypes according to the cognitive domains involved: amnestic MCI, multiple-domain amnestic MCI, non-amnestic MCI and multiple-domain non-amnestic MCI. While neurocognitive deficits are a constituent of the diagnosis of these subtypes, the question of how they refer to the cognitive reserve still needs to be clarified. Methods: We examined neuropsychological deficits in healthy controls, patients with MCI and patients with mild AD (n = 485) derived from a memory clinic. To reduce the number of neuropsychological variables, a factor analysis with varimax rotation was calculated. In a second step, diagnostic groups including MCI subtypes were compared with respect to their clinical and neuropsychological characteristics including cognitive reserve. Results: Most MCI patients showed the amnestic multiple-domain subtype followed by the pure amnestic subtype, while the non-amnestic subtypes were rare. The amnestic subtype displayed a significantly higher level of cognitive reserve and higher MMSE scores than the amnestic multiple-domain subtype, which was in most cases characterized by additional psychomotor and executive deficits. Conclusions: These findings confirm earlier reports revealing that the amnestic multiple-domain subtype is the most frequent one and indicating that a high cognitive reserve may primarily prevent psychomotor and executive deficits in MCI.

Keywords:
Alzheimer’s disease, Mild cognitive impairment, CERAD-NP, Cognitive reserve
1.
Schröder J, Pantel J: Die leichte kognitive Beeinträchtigung. Klinik, Diagnostik, Therapie und Prävention im Vorfeld der Alzheimer-Demenz. Stuttgart, Schattauer, 2011.
2.
Flicker C, Ferris SH, Reisberg B: Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;41:1006-1009.
3.
Berg L, Danziger WL, Storandt M, Coben LA, Gado M, Hughes CP, Knesevich JP, Botwinick J: Predictive features in mild senile dementia of the Alzheimer type. Neurology 1984;34:563-569.
4.
Levy R: Aging-Associated Cognitive Decline. Int Psychogeratr 1994;6:63-68.
5.
Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
6.
Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CRJ, Galasko DR, Doody R, et al: Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004;61:59-66.
7.
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L-O, Nordberg A, Bäckman L, Albert M, Almkvist O, et al: Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
8.
Han JW, Kim TH, Lee SB, Park JH, Lee JJ, Huh Y, Park JE, Jhoo JH, Lee DY, Kim KW: Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimers Dement 2012;8:553-559.
9.
Schönknecht P, Pantel J, Kruse A, Schröder J: Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Am J Psychiatry 2005;162:2071-2077.
10.
Alladi S, Arnold R, Mitchell J, Nestor PJ, Hodges JR: Mild cognitive impairment: applicability of research criteria in a memory clinic and characterization of cognitive profile. Psychol Med 2006;36:507-515.
11.
Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, et al: Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the European prospective DESCRIPA study. Dement Geriatr Cogn Disord 2013;36:1-19.
12.
Dos Santos V, Thomann PA, Wüstenberg T, Seidl U, Essig M, Schröder J: Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2010;23:1-10.
13.
Steffener J, Stern Y: Exploring the neural basis of cognitive reserve in aging. Biochim Biophys Acta 2012;1822:467-473.
14.
Stern Y: Cognitive reserve. Neuropsychologia 2009;47:2015-2028.
15.
Bickel H, Cooper B: Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study. Psychol Med 1994;24:179-192.
16.
Paykel ES, Brayne C, Huppert FA, Gill C, Barkley C, Gehlhaar E, Beardsall L, Girling DM, Pollitt P, O'Connor D: Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994;51:325-332.
17.
Stern Y, Gurland B, Tatemichi T, Tang M, Wilder D, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.
18.
Evans D, Hebert L, Beckett L, Scherr P, Albert M, Chown M, Pilgrim D, Taylor O: Education and other measures of socioeconomic status and risk of incidence Alzheimer's disease in a defined population of older persons. Arch Neurol 1997;54:1399-1405.
19.
Schmand B, Smit J, Geerlings M, Lindeboom J: The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis. Psychol Med 1997;27:1337-1344.
20.
Jorm AF, Rodgers B, Henderson A, Korten A, Jacomb PA, Christensen H, Mackinnon A: Occupation type as a predictor of cognitive decline and dementia in old age. Age Ageing 1998;27:477-483.
21.
Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino: The preclinical phase of Alzheimer disease. A 22-year prospective study of Framingham Cohort. Arch Neurol 2000;57:808-813.
22.
Helmer C, Lettenneur L, Rouch I, Richard-Harston S, Barberger-Gateau P, Fabrigoule C, Orgogozo J, Dartigues J: Occupation during life and risk of dementia in French elderly community residents. J Neurol Neurosurg Psychiatry 2001;71:303-309.
23.
Scarmeas N, Levy G, Tang M, Manly J, Stern Y: Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 2001;57:2236-2242.
24.
Karp A, Kåreholt I, Qiu C, Bellander T, Winblad B, Fratiglioni L: Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease. Am J Epidemiol 2004;159:175-183.
25.
Valenzuela MJ, Sachdev P: Brain reserve and dementia: a systematic review. Psychol Med 2006;36:441-454.
26.
Crook T, Bartus RT, Ferris SH: Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health work group. Dev Neuropsychol 1986;2:261-276.
27.
Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
28.
Heyman A, Fillenbaum GG: Overview: clinical sites, case material and special studies. Neurology 1997;49:2-6.
29.
Härting C, Markowitsch HJ, Neufeld H, Calabrese P, Deisinger K, Kessler J: Wechsler Memory Scale - Revised Edition, German Edition. Manual. Bern, Huber, 2000.
30.
Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
31.
Reitan RM, Wolfson D: The Trail Making Test as an initial screening procedure for neuropsychological impairment in older children. Arch Clin Neuropsychol 2004;19:281-288.
32.
Tombaugh TN: Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004;19:203-214.
33.
Brauns H, Steinmann S: Educational reform in France, West-Germany, and the United Kingdom. Updating the CASMIN educational classification. ZUMA Nachrichten 1999;447-44.
34.
Lampert T, Kroll L, Mütters S, Stolzenberg H: Measurement of socioeconomic status in the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt 2013;56:631-636.
35.
Ghaffar O, Fiati M, Feinstein A: Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS One 2012;7:e47206.
36.
Geider FJ, Rogge K-E, Schaaf HP: Einstieg in die Faktorenanalyse. Heidelberg, Quelle & Meyer, 1982.
37.
Yang FM, Grigorenko A, Tommet D, Farias S, Mungas D, Bennett DA, Jones RN, Crane PK: AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol 2013;35:24-34.
38.
Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, et al: Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006;63:916-924.
39.
Rasquin SM, Lodder J, Visser PJ, Lousberg R, Verhey FR: Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study. Dement Geriatr Cogn Disord 2005;19:113-119.
40.
Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL: Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 2001;58:411-416.
41.
Palmer K, Backman L, Winblad B, Fratiglioni L: Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 2008;16:603-611.
42.
Mitchell AJ, Shiri-Feshki M: Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252-265.
43.
Maioli F, Coveri M, Pagni P, Chiandetti C, Marchetti C, Ciarrocchi R, Ruggero C, Nativio V, Onesti A, D'Anastasio C, et al: Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Arch Gerontol Geriatr 2007;44(suppl 1):233-241.
44.
Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Pantieri G, Mariani E: Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord 2006;21:51-58.
45.
Busse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG: Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006;67:2176-2185.
46.
Barth S, Schönknecht P, Pantel J, Schröder J: Neuropsychologische Profile in der Demenzdiagnostik: Eine Untersuchung mit der CERAD-NP-Testbatterie. Fortschr Neurol Psychiatr 2005;73:568-576.
47.
Pantel J, Schröder J, Schmitt R, Schad LR, Knopp MV, Geissler M, Uhde W, Blüml S, Friedlinger M, Klemenz M, et al: Quantitative Magnetresonanztomografie und Schweregrad der Defizite bei der Demenz vom Alzheimertyp. Nervenarzt 1996;67:46-52.
48.
Perry RJ, Hodges JR: Attention and executive deficits in Alzheimer's disease. A critical review. Brain 1999;122:383-404.
49.
Chen P, Ratkliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M: Patterns of cognitive decline in presymptomatic Alzheimer disease. Arch Gen Psychiatry 2001;58:853-858.
50.
Albert MS: Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci USA 1996;93:13547-13551.
51.
Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C: Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008;14:266-278.
52.
Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried L-P, Carlson MC, Newman AB, Kuller L: Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology 2004;63:2341-2347.
53.
Tierney MC, Yao C, Kiss A, McDowell I: Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 2005;64:1853-1859.
54.
Bäckman L, Jones S, Berger A-K, Jonsson Laukka E, Small BJ: Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005;19:520-531.
55.
Tatsuoka C, Tseng H, Jaeger J, Varadi F, Smith MA, Yamada T, Smyth KA, Lerner AJ; Alzheimer's Disease Neuroimaging Initiative: Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment. Alzheimers Res Ther 2013;5:14.
56.
Gorenc-Mahmutaj L, Degen C, Wetzel P, Urbanowitsch N, Funke J, Schröder J: The positivity effect on the intensity of experienced emotion and memory performance in mild cognitive impairment and dementia. Dement Geriatr Cogn Disord 2015;5:233-243.
57.
Stern Y, Alexander GE, Prohovnik I, Mayeux R: Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992;32:371-375.
58.
Alexander GE, MFurey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB: Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry 1997;154:165-172.
59.
Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V, Sorbi S, Cappa SF, Padovani A, Fazio F, et al: Education and occupation as proxies for reserve in aMCI converters and AD. Neurology 2008;71:1342-1349.
60.
Stuss DT, Bisschop SM, Alexander MP, Levine B, Katz D, Izukawa D: The Trail-Making Test: a study in focal lesion patients. Psychol Assess 2001;13:230-239.
61.
Hunt A, Haberkorn U, Schröder J, Schönknecht P: Neural correlates of executive dysfunction in prodromal and manifest Alzheimer's disease. J Gerontopsychol Geriatr Psychiatry 2011;24:77-81.
62.
Meguro K, Shimada M, Yamaguchi S, Ishizaki J, Ishii H, Shimada M, Sato M, Yamadori A, Yasuqoshi S: Cognitive function and frontal lobe atrophy in normal elderly adults: implications for dementia not as aging-related disorders and the reserve hypothesis. Psychiatry Clin Neurosci 2001;55:565-572.
63.
Roldán-Tapia L, Garcia J, Cánovas R, León I: Cognitive reserve, age, and their relation to attentional and executive functions. Appl Neuropsychol 2012;19:2-8.
64.
Schaie KW: Intellectual Development in Adulthood: The Seattle Longitudinal Study. Cambridge, Cambridge University Press, 1996.
65.
Smart EL, Gow AJ, Deary IJ: Occupational complexity and lifetime cognitive abilities. Neurology 2014;83:2285-2291.
66.
Then FS, Luck T, Luppa M, König H-H, Angermeyer MC, Riedel-Heller SG: Differential effects of enriched environment at work on cognitive decline in old age. Neurology 2015;84:2169-2176.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.